Vinod P Balachandran

24PUBLICATIONS
221CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyGenetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 07, 2026
Pancreatic cancer.

|Mar 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

Wungki Park, Shigeaki Umeda, Marc Hilmi

|Mar 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Wungki Park, Catherine A O'Connor, Joanne F Chou

|Sep 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.

Wungki Park, Catherine O'Connor, Joanne Chou

|Jul 23, 2025
The colorectal liver metastasis growth pattern phenotype is not dependent on genotype.

Diederik J Höppener, Sanne M L Verheul, Pieter M H Nierop

|Feb 19, 2025
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer.

Zachary Sethna, Pablo Guasp, Charlotte Reiche

Pageof 4

Frequent Collaborators

8 joint publications

Kevin Soares

8 joint publications

Eileen O'Reilly

8 joint publications

Christine Iacobuzio-Donahue

8 joint publications

Alice Wei